Evidence map›Paper›PMID 22194793›Full record

ArticlePloS one2011

FAK deletion promotes p53-mediated induction of p21, DNA-damage responses and radio-resistance in advanced squamous cancer cells.

Kathryn Graham, Kim Moran-Jones, Owen J Sansom, Valerie G Brunton, Margaret C Frame

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Trial
  2. Beyond DNA damage: 3D tumor models and the integrin mechanobiology of radioresistance.Journal of experimental & clinical cancer research : CR · 2026
    Review
  3. Inactivation of Focal Adhesion Kinase FAK Rapidly Abrogates Keratinocyte Entry in Mitosis via Rho-Associated Kinase, Resulting in Squamous Differentiation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Article
  5. Multiple functions of p21 in cancer radiotherapy.Journal of cancer research and clinical oncology · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Coelomic Fluid ofTheScientificWorldJournal · 2019
    Article
  11. Article
  12. Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Article
  13. Article
  14. Molecular Pathways: Endothelial Cell FAK-A Target for Cancer Treatment.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Review
  15. Article
  16. Article
  17. Review
  18. Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1.).Journal of molecular and cellular cardiology · 2014
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kathryn GrahamThe Beatson Institute for Cancer Research, Garscube Estate, Bearsden, Glasgow, Scotland.
Kim Moran-Jones
Owen J Sansom
Valerie G Brunton
Margaret C Frame
Cancer Research UK Scotland Institute · GBEdinburgh Cancer Research · GB

Funding

Cancer Research UK 12481Cancer Research UK C157/A9148
6 · The paper itself

Abstract

Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that is elevated in a variety of human cancers. While FAK is implicated in many cellular processes that are perturbed in cancer, including proliferation, actin and adhesion dynamics, polarisation and invasion, there is only some limited information regarding the role of FAK in radiation survival. We have evaluated whether FAK is a general radio-sensitising target, as has been suggested by previous reports. We used a clean genetic system in which FAK was deleted from mouse squamous cell carcinoma (SCC) cells (FAK -/-), and reconstituted with exogenous FAK wild type (wt). Surprisingly, the absence of FAK was associated with increased radio-resistance in advanced SCC cells. FAK re-expression inhibited p53-mediated transcriptional up-regulation of p21, and a sub-set of other p53 target genes involved in DNA repair, after treatment with ionizing radiation. Moreover, p21 depletion promoted radio-sensitisation, implying that FAK-mediated inhibition of p21 induction is responsible for the relative radio-sensitivity of FAK-proficient SCC cells. Our work adds to a growing body of evidence that there is a close functional relationship between integrin/FAK signalling and the p53/p21 pathway, but demonstrates that FAK's role in survival after stress is context-dependent, at least in cancer cells. We suggest that there should be caution when considering inhibiting FAK in combination with radiation, as this may not always be clinically advantageous.

Indexed as

DNA DamageGene DeletionRadiation ToleranceAnimalsCarcinoma, Squamous CellCell Line, TumorCyclin-Dependent Kinase Inhibitor p21DNA RepairFocal Adhesion Protein-Tyrosine KinasesGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansMiceNeoplasm StagingRadiation, IonizingTranscription, GeneticCyclin-Dependent Kinase Inhibitor p21Focal Adhesion Protein-Tyrosine KinasesTumor Suppressor Protein p53

Identifiers

PMID22194793
PMCPMC3237418
OpenAlexW2139807762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.